Achieving Sustained Treatment Response: The Need for Immunotherapy in Chronic HBV
Time: 1:30 pm
day: Day Two
Details:
• Evaluating the role of T-cells in clearing virus infections, including HBV epitope targets for CD4+ and CD8+ T cells
• Understanding the analogy between HPV and HBV chronic infections with attention to the special role of the liver
• Reviewing the synthetic Long Peptide vaccine technology in HBV
• Exploring the relationship between immune response and clinical response
